Clinicians frequently encounter diagnostic dilemmas when patients present with sudden visual field loss despite normal fundus examinations. In recent ophthalmic investigations, acute outer retinopathy has emerged as an aggressive entity within the outer retinopathy spectrum. Historically, practitioners struggled to identify microstructural neurosensory injury during early ophthalmoscopy. Today, spectral-domain optical coherence tomography provides vital cross-sectional insight into subtle outer retinal architecture. Consequently, clinicians can detect photoreceptor disruption far earlier than conventional fundus examination permits. Therefore, recognizing these early imaging findings remains essential for prompt clinical management.

The Pathophysiological Context of Acute Outer Retinopathy

Acute zonal occult outer retinopathy typically manifests as sudden visual field loss and photopsia, predominantly affecting young women. Over recent years, researchers identified acute outer retinopathy as a distinct clinical subset characterized by rapid progression. Although both conditions share symptomatic features, acute outer retinopathy demonstrates an unusually steep trajectory of photoreceptor disruption. Autoimmune mechanisms and post-viral inflammatory cascades likely trigger this destructive neurosensory process. Specifically, inflammatory mediators target photoreceptor segments and adjacent outer retinal structures. Furthermore, cellular stress rapidly disrupts axonal transport along photoreceptor fibers. Because the inner retina appears normal during early ophthalmoscopy, clinicians often face diagnostic delays. However, subclinical cellular injury propagates rapidly across the outer retina. Histopathological models indicate that rapid metabolic collapse occurs within photoreceptors before pigmentary changes emerge. Therefore, recognizing acute outer retinopathy as an urgent diagnostic priority prevents catastrophic oversights. Ultimately, understanding this distinct pathophysiology helps clinicians distinguish fulminant outer retinopathies from indolent conditions.

Unpacking the Angular Sign of Henle Fiber Layer Hyperreflectivity

The angular sign of Henle fiber layer hyperreflectivity, termed the ASHH sign, serves as an indispensable optical biomarker. This distinctive sign appears on optical coherence tomography as an oblique, hyperreflective band traversing Henle's fiber layer. Anatomically, this hyperreflectivity connects the outer plexiform layer with the disrupted ellipsoid zone. When acute ischemic or inflammatory insults strike the macula, photoreceptor axons undergo swift cytotoxic swelling. Consequently, optical properties along these oblique axonal pathways alter, producing intense reflectivity on tomography. Moreover, clinicians observe this biomarker across diverse retinal pathologies, including contusion maculopathy and paraneoplastic retinopathy. In acute outer retinopathy, however, the ASHH sign signals immediate, severe photoreceptor structural destabilization. Clinicians must appreciate that this angular hyperreflectivity precedes visible outer retinal thinning or pigmentary atrophy. In addition, serial tomography demonstrates gradual fading of the hyperreflective band over subsequent weeks. Unfortunately, this resolution frequently heralds permanent outer retinal atrophy. Therefore, detecting the ASHH sign provides unequivocal proof of acute photoreceptor injury before fundus changes appear.

Clinical Presentation and Multimodal Diagnostic Evaluation

Patients afflicted with acute outer retinopathy typically present with sudden temporal or nasal scotomas alongside prominent photopsia. Visual acuity can deteriorate precipitously within days, plunging from mild blurriness to counting fingers or hand movements. During the earliest phase, conventional fundus examination often appears normal or shows only faint grayish retinal discoloration. For this reason, practitioners must employ multimodal retinal imaging without hesitation. Fundus autofluorescence represents an indispensable diagnostic modality in this evaluation. Specifically, autofluorescence reveals distinct hyperautofluorescent patterns that outline active zones of outer retinal damage. These lesions may follow perivenular, sectoral, spot-like, or peripapillary annular distributions. Meanwhile, fluorescein angiography and indocyanine green angiography usually remain unremarkable, effectively ruling out primary choroiditis and vasculitis. Simultaneously, optical coherence tomography reliably confirms disruption of the ellipsoid zone and external limiting membrane. Furthermore, multifocal electroretinography demonstrates profound localized amplitude loss matching structural lesions. Consequently, combining functional perimetry with cross-sectional tomography enables definitive diagnosis even when ophthalmoscopy appears reassuring.

Therapeutic Challenges and Corticosteroid Resistance

Managing acute outer retinopathy poses immense challenges for vitreoretinal specialists and medical ophthalmologists. Because clinicians suspect autoimmune or inflammatory mechanisms, high-dose systemic corticosteroids remain standard initial therapy. Practitioners frequently administer intravenous methylprednisolone pulse therapy followed by slowly tapered oral prednisolone regimens. However, therapeutic outcomes remain poor across reported cases. As documented in recent literature, visual acuity often deteriorates to hand movements despite aggressive, early immunosuppression. Furthermore, secondary immunosuppressive agents and intravenous immunoglobulins demonstrate inconsistent results in arresting disease progression. In addition, some physicians prescribe empirical systemic antivirals when patients report antecedent viral illness. Nonetheless, controlled clinical trials evaluating effective treatments remain unavailable. This frequent lack of corticosteroid responsiveness highlights our incomplete understanding of cellular pathophysiology. Perhaps irreversible axonal injury and apoptotic cascades establish themselves within hours of symptom onset. Therefore, prompt clinical recognition remains crucial to optimize therapeutic timing. Clinicians must communicate these therapeutic limitations transparently with patients and families.

Structure-Function Dissociation and Long-Term Visual Prognosis

A particularly intriguing feature of acute outer retinopathy involves the marked dissociation between structural reconstitution and functional visual recovery. Over several months, follow-up optical coherence tomography scans may show partial restoration of the external limiting membrane. In some patients, the ellipsoid zone partially reforms and outer retinal architecture stabilizes. Nevertheless, visual acuity frequently remains severely depressed, leaving permanent dense scotomas. This striking functional dissociation suggests that morphological recovery does not guarantee restored photoreceptor phototransduction. Neurobiological studies suggest that surviving photoreceptors often maintain disorganized disc architecture. Furthermore, synaptic connectivity between injured photoreceptors and second-order bipolar neurons may suffer permanent damage during the acute insult. Consequently, visual signals fail to transmit effectively despite partial anatomical realignment. Long-term management necessitates regular visual field testing and tomography to monitor the fellow eye. Because bilateral involvement occurs in a notable subset of cases, clinicians must instruct patients to report new photopsias immediately. Ultimately, developing effective neuroprotective therapies represents a crucial frontier in managing this devastating outer retinopathy.

What is the clinical significance of the ASHH sign on optical coherence tomography?

The angular sign of Henle fiber layer hyperreflectivity represents an invaluable optical coherence tomography biomarker signifying hyperacute photoreceptor axon distress. This distinctive oblique band appears when mechanical, inflammatory, or ischemic stress induces rapid intracellular edema within Henle's layer. Consequently, it alerts clinicians to severe neurosensory damage before funduscopy reveals visible abnormalities. Recognizing this sign expedites prompt diagnostic workups, facilitates timely anti-inflammatory interventions, and prevents misattributing acute visual deficits to non-organic pathology.

How does acute outer retinopathy differ from classic AZOOR?

Although acute outer retinopathy belongs to the broad acute zonal occult outer retinopathy spectrum, it displays a remarkably aggressive clinical trajectory. Patients experience rapid visual acuity deterioration, often plummeting to hand movements within days. Furthermore, acute outer retinopathy exhibits distinct hyperautofluorescent patterns and early Henle fiber layer hyperreflectivity on tomography. While classic AZOOR frequently stabilizes with preserved central acuity, acute outer retinopathy often leads to permanent outer retinal atrophy despite high-dose corticosteroid treatment.

Why does visual function fail to recover despite anatomical healing on OCT?

This clinical paradox stems from severe structure-function dissociation following acute neurosensory injury. Although spectral-domain optical coherence tomography may demonstrate partial reconstitution of the external limiting membrane and ellipsoid zone, surviving photoreceptors frequently exhibit disorganized inner disc architecture. Additionally, the initial inflammatory insult permanently disrupts synaptic transmissions between photoreceptor terminals and bipolar cells. Consequently, phototransduction remains critically compromised, leaving patients with persistent visual field scotomas and poor visual acuity despite visible structural restoration.

Disclaimer: This content is for informational and educational purposes only, and should not be taken as medical advice. It is not intended for use in the diagnosis or treatment of any health condition. Consult a licensed healthcare provider for personalized medical guidance. Refer to the latest local and national guidelines for clinical practice.

References

1. Corcuera Munguía M et al. When OCT Speaks Before the Fundus Does: Early ASHH Sign Revealing Acute Outer Retinopathy. Ocul Immunol Inflamm. 2026 Sep 18. doi: 10.1080/09273948.2026.2734568. PMID: 42759038.
2. Ramtohul P, Malclès A, Denis P, et al. Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy. Ophthalmol Retina. 2025;9(6):543-554.
3. Flindris K, Kaliardas A, Koumpoulis I, Melissourgos I. A Case Series of Angular Sign of Henle Fiber Layer Hyperreflectivity (ASHH): A Novel Optical Coherence Tomography (OCT) Biomarker. Cureus. 2025;17(10):e71234.
4. Mrejen S, Khan S, Gallego-Pinazo R, Jampol LM, Yannuzzi LA. Acute Zonal Occult Outer Retinopathy: A Classification Based on Multimodal Imaging. JAMA Ophthalmol. 2014;132(6):717-724.